NCCN 3rd Annual Congress:
Hematologic Malignancies™
Agenda
Friday, September 5, 2008
Registration, Breakfast, and Exhibits
7:30 - 8:45 AM
Welcome
8:45 – 8:55 AM
Andrew D. Zelenetz, MD, PhD
Memorial Sloan-Kettering Cancer Center
Lymphomas
Treatment of Acute Lymphocytic Leukemia
8:55 – 9:55 AM
L. Andres Sirulnik, MD, PhD
Dana-Farber/Brigham and Women`s Cancer Center
Treatment of Cutaneous T-cell Lymphoma
10:00 – 10:45 AM
Steven M. Horwitz, MD
Memorial Sloan-Kettering Cancer Center
Break and Exhibits
10:45 – 11:05 AM
Radioimmunotherapy in Lymphomas
11:05 – 11:50 AM
Andrew D. Zelenetz, MD, PhD
Memorial Sloan-Kettering Cancer Center
Lunch and Exhibits
11:50 AM – 12:50 PM
The Evolving Role of Multi-Modality Therapy in Hodgkin’s Lymphoma
12:50 – 1:35 PM
Leo I. Gordon, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Role of PET in the Diagnosis and Management of Lymphomas
1:40 – 2:25 PM
Donald A. Podoloff, MD
The University of Texas MD Anderson Cancer Center
Break and Exhibits
2:25 – 2:45 PM
Chronic Myelogenous Leukemia
Update on Frontline Therapy of CML with Imatinib and Results with Second Generation Tyrosine Kinase Inhibitors
2:45 – 3:30 PM
Susan O’Brien, MD
The University of Texas MD Anderson Cancer Center
Combating Progressive Disease by Monitoring and Early Detection: War and PCR
3:35 – 4:20 PM
Jerald P. Radich, MD
Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance
Closing Remarks
4:25 – 4:30 PM
Andrew D. Zelenetz, MD, PhD
Memorial Sloan-Kettering Cancer Center
Reception and Exhibits
4:30 – 6:15 PM
Saturday, September 6, 2008
8:00 AM – 12:45 PM
Registration & Breakfast
7:30 – 8:00 AM
Welcome
8:00 – 8:05 AM
Andrew D. Zelenetz, MD, PhD
Memorial Sloan-Kettering Cancer Center
Supportive Care
Anemia and Myelodysplastic Syndromes
8:05 – 8:50 AM
Peter L. Greenberg, MD
Stanford Comprehensive Cancer Center
Panel Discussion – ESAs: Risk Benefit Analysis
8:55 – 9:55 AM
Pamela S. Becker, MD, PhD
University of Washington Medical Center
Charles L. Bennett, MD, PhD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Eric H. Kraut, MD
Arthur G. James Cancer Hospital & Richard J. Solove Research Institute at The Ohio State University
Issues in Advanced Directives: Changing Goals and Realities with Advancing Disease
10:00 – 10:45 AM
Cameron Muir, MD
Capital Hospice
Break
10:45 – 11:05 AM
Multiple Myeloma
Supportive Care in Multiple Myeloma
11:05 – 11:50 AM
Kenneth C. Anderson, MD
Dana-Farber/Brigham and Women’s Cancer Center
Sequencing of Therapies for Multiple Myeloma
11:55 AM – 12:40 PM
Seema Singhal, MD
Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Closing Remarks
12:40 – 12:45 PM
Andrew D. Zelenetz, MD, PhD
Memorial Sloan-Kettering Cancer Center
View information on the NCCN 1st Annual Forum: Innovative Diagnostics & Therapeutics in Cancer Care™.
Last update 06/23/2008. Subject to change.
|
E-mail
Print
Mark